CBOA
TTPH

Commonwealth Bank of Australia’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Commonwealth Bank of Australia’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-690
Closed -$150K – 1097
2014
Q1 		$150K Buy
690
+20
+3% +$5.57K ﹤0.01% 1219
2013
Q4 		$181K Buy
+670
New +$160K ﹤0.01% 1187

Other funds holding TTPH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commonwealth Bank of Australia's TTPH Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2014, closing a stake of 690 shares — an estimated $150K sold.

Commonwealth Bank of Australia first reported a position in TTPH in Q4 2013 and held it in 2 quarters. The position peaked at $181K in Q4 2013. 64 funds tracked by Wall St. Rank hold TTPH as of Q2 2014.

  • Commonwealth Bank of Australia reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 690 Tetraphase Pharmaceuticals, Inc. shares in Q2 2014, an estimated $150K.
  • Commonwealth Bank of Australia first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 2 quarters.
  • Commonwealth Bank of Australia's Tetraphase Pharmaceuticals, Inc. position peaked at $181K in Q4 2013.
  • 64 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.